Mylan Inc Q1 2018 Big Money Sentiment Better Than Expected: at 1

June 27, 2018 - By Robert Judd

Mylan N.V. (NASDAQ:MYL) Corporate Logo

Mylan Inc’s Sentiment

In Q1 2018 Mylan Inc (NASDAQ:MYL) big money sentiment decreased to 1, according to SEC filings. That’s down -2.00, from 2017Q4’s 3. 3 active investment managers increased and started new holdings, while 3 sold and decreased positions in Mylan Inc so the sentiment fall. These funds own 190,596 shares, that’s down from 292,846 shares in 2017Q4. Funds holding Mylan Inc in top 10 changed to 0 from 0 for the same number . In total 1 funds closed positions, 2 reduced and 0 increased. Also 3 funds bought new Mylan Inc stakes.

Significant Mylan Inc Investors

Van Hulzen Asset Management Llc owns 30,685 shares in Mylan Inc as of Q1 2018. Mylan Inc’s shareholder Gulf International Bank (Uk) Ltd owns 139,000 shares as of Q1 2018. Eqis Capital Management Inc. reported 6,506 shares. The California-based fund Gemmer Asset Management Llc have invested about 0% of the investment professional’s stock portfolio in Mylan Inc. The Pennsylvania-based fund Vantage Investment Advisors Llc holds 337 shares or 0% of their fund portfolio.

Mylan N.V., together with its subsidiaries, develops, licenses, makes, markets, and distributes generic, brand name, and over-the-counter products worldwide.The firm is worth $19.82 billion. The firm operates through three divisions: North America, Europe, and Rest of World.The P/E ratio is 28.39. It offers pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized, and cream or ointment forms.

The stock increased 0.39% or $0.15 during the last trading session, hitting $38.44.Mylan N.V. has volume of 1.25M shares. Since June 27, 2017 MYL has declined 1.13% and is downtrending. The stock underperformed the S&P 500 by 13.70%.

Mylan N.V. (NASDAQ:MYL)’s earnings report is anticipated on August, 8., according to Zacks. Last year’s earnings per share was $1.1, while now analysts expect change of 11.82 % up from current $1.23 earnings per share. In case of $1.23 earnings per share MYL’s profit could be $634.04M. Wall Street now forecasts 28.13 % EPS growth despite Mylan N.V. previous quarter’s EPS of $0.96.

Gulf Intl Retail Bank (Uk) Limited reported 139,000 shs. Eqis Management holds 6,506 shs or 0.01% of its capital. Vantage Investment Limited Liability has 337 shs for 0% of their capital. 12 are owned by Gemmer Asset Lc. Van Hulzen Asset Management Limited Liability Corp has 30,685 shs for 0.39% of their capital.

Mylan N.V. (NASDAQ:MYL) Ratings Coverage

Total analysts of 15 have positions in Mylan (NASDAQ:MYL) as follows: 11 rated it a “Buy”, 0 with “Sell” and 4 with “Hold”. The positive are 73%. The firm has $5900 highest while $41 is the lowest target. The average target $49.67 is 29.21% above the last ($38.44) price. Since January 3, 2018 according to StockzIntelligence Inc Mylan has 20 analyst reports. On Tuesday, June 5 the firm earned “Buy” rating by Guggenheim. On Tuesday, March 6 Morgan Stanley upgraded Mylan N.V. (NASDAQ:MYL) rating. Morgan Stanley has “Overweight” rating and $50 target. On Thursday, January 25 the rating was maintained by Susquehanna with “Buy”. On Thursday, January 18 the firm has “Hold” rating given by Wells Fargo. In Monday, April 9 report Morgan Stanley maintained it with “Buy” rating and $5000 target. On Thursday, January 11 Goldman Sachs upgraded Mylan N.V. (NASDAQ:MYL) rating. Goldman Sachs has “Buy” rating and $52.0 target. On Thursday, May 31 Wells Fargo maintained Mylan N.V. (NASDAQ:MYL) rating. Wells Fargo has “Market Perform” rating and $41 target. On Thursday, March 1 the firm earned “Buy” rating by UBS. On Thursday, January 18 the company was maintained by Mizuho. On Tuesday, May 29 Bank of America maintained Mylan N.V. (NASDAQ:MYL) with “Neutral” rating.

A couple more Mylan N.V. (NASDAQ:MYL) news were announced by: which released on June 18, 2018 “Mylan (MYL) Announces Launch of Generic Angiomax Injection”, also on June 27, 2018 announced “Mylan (MYL) Removed from Citi’s US Focus List”, the next is “Watch Out Amgen, Here Comes Mylan” on June 05, 2018. has article titled “Mylan: A Margin Of Safety Case Study”.

Mylan N.V. (NASDAQ:MYL) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: